Показать сокращенную информацию
dc.contributor.author | Dudnyk, V. M. | en |
dc.contributor.author | Andrikevych, I. I. | en |
dc.contributor.author | Furman, V. H. | en |
dc.contributor.author | Buglova, N. O. | en |
dc.contributor.author | Kutsak, O. V. | en |
dc.contributor.author | Stetsun, O. O. | en |
dc.date.accessioned | 2021-09-14T10:10:48Z | |
dc.date.available | 2021-09-14T10:10:48Z | |
dc.date.issued | 2021 | |
dc.identifier.citation | Multisystem inflammatory syndrome in children - a clinicalexample in pediatrics / V. M. Dudnyk, V. Н. Furman, I. I. Andrikevych [et al.] // Вісник Вінницького національного медичного університету. - 2021. - Т. 25, № 2. – С. 258-260. | en |
dc.identifier.uri | https://dspace.vnmu.edu.ua/123456789/5377 | |
dc.description.abstract | Peculiarities of clinical course and differential diagnosis of multisystem inflammatory syndrome (MIS-C) in childrenwith coronavirus infection are described. The main features of this disease are long-term fever, multiorgan dysfunction, laboratorysigns of inflammation and positive tests for SARS-CoV-2 (polymerase chain reaction using reverse transcription (RT-PCR), antigentest or positive serological test). The criteria of the World Health Organization (WHO) and the US Centers for Disease Control and Prevention (CDC) are used to confirm the MIS-C diagnosis. | uk_UA |
dc.language.iso | en | en |
dc.subject | children | en |
dc.subject | SARS-CoV-2 | en |
dc.subject | multisystem inflammatory syndrome | en |
dc.subject | MIS-C | |
dc.subject | Kawasaki disease | en |
dc.title | Multisystem inflammatory syndrome in children - a clinicalexample in pediatrics | en |
dc.type | Article | en |